Normal view MARC view ISBD view

Proposed health care payment model is based on so-called evidence-informed case rates. [electronic resource]

Producer: 20070621Description: 79 p. digitalISSN:

1068-8838

Subject(s):

In: Hospitals & health networks vol. 81

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: News

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5
6
7
8
9
10
11
12

1 Pretransplant blood transfusion with cyclophosphamide: efficacious means of prolonging allograft survival.
by Lagodzinski, Z
2 Oral heparin prolongs survival of skin allografts.
by Górski, A
3 Nitrogranulogen-dependent inhibition of antibody synthesis. II. In vivo studies in mice.
by Lagodziński, Z
4 Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice.
by Lagodzinski, Z
5 Immunosuppressive action of low-dose heparin. Effect on skin allograft survival.
by Lagodzinski, Z
6 Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro.
by Wasik, M
7 Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
by Wasik, M
8 Effect of FK 506 on B-cell responses.
by Lagodziński, Z
9 TFX modulates the immunosuppressive effect of cyclophosphamide on antibody production in mice.
by Paczek, L
10 New strategies of heparin treatment used to prolong allograft survival.
by Gorski, A
11 Class II antigens and interleukin 2 expression in renal allograft recipients.
by Glapinski, T
12 Blood transfusion induces alterations in the circulation of immunoglobulin-secreting cells and activates helper T cells for Ig synthesis.
by Górski, A

Close